Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs
Cells · 17.12.2024 · 13 (24) · 2085
DOI: 10.3390/cells13242085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 17.12.2024. Verfasst von Daria Lanskikh und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Life Sciences, Far Eastern Federal University, 690922 Vladivostok, Russia. Hauptthemen laut MEDLINE: Glioma, Drug Screening Assays, Antitumor, Brain Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 320 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Gliomas are a group of primary brain tumors characterized by their aggressive nature and resistance to treatment. Infiltration of surrounding normal tissues limits surgical approaches, wide inter- and intratumor heterogeneity hinders the development of universal therapeutics, and the presence of the blood–brain barrier reduces the efficiency of their delivery. As a result, patients diagnosed with gliomas often face a poor prognosis and low survival rates. The spectrum of anti-glioma drugs used in clinical practice is quite narrow. Alkylating agents are often used as first-line therapy, but their effectiveness varies depending on the molecular subtypes of gliomas. This highlights the need for new, more effective therapeutic approaches. Standard drug-screening methods involve the use of two-dimensional cell cultures. However, these models cannot fully replicate the conditions present in real tumors, making it difficult to extrapolate the results to humans. We describe the advantages and disadvantages of existing glioma cell-based models designed to improve the situation and build future prospects to make drug discovery comprehensive and more effective for each patient according to personalized therapy paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Life Sciences, Far Eastern Federal University, 690922 Vladivostok, Russia.
ORCID-Profile: Daria Lanskikh, Olga Kuziakova, Ivan Baklanov, Alina Penkova, Ivan Buriak, Valeriia Zhmenia, Vadim Kumeiko
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Lanskikh, D., Kuziakova, O., Baklanov, I., Penkova, A., Doroshenko, V., Buriak, I., Zhmenia, V., & Kumeiko, V. (2024). Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs. Cells, 13(24), 2085. https://doi.org/10.3390/cells13242085
Vancouver
Lanskikh D, Kuziakova O, Baklanov I, Penkova A, Doroshenko V, Buriak I, et al. Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs. Cells. 2024;13(24):2085. doi:10.3390/cells13242085
BibTeX
@article{Lanskikh2024,
author = {Lanskikh, Daria and Kuziakova, Olga and Baklanov, Ivan and Penkova, Alina and Doroshenko, Veronica and Buriak, Ivan and Zhmenia, Valeriia and Kumeiko, Vadim},
title = {Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs},
journal = {Cells},
year = {2024},
volume = {13},
number = {24},
pages = {2085},
doi = {10.3390/cells13242085}
}
EUVIMED